These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26340409)

  • 21. Differential type I interferon activation and susceptibility of dendritic cell populations to porcine arterivirus.
    Loving CL; Brockmeier SL; Sacco RE
    Immunology; 2007 Feb; 120(2):217-29. PubMed ID: 17116172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production.
    Subramanya S; Kim SS; Abraham S; Yao J; Kumar M; Kumar P; Haridas V; Lee SK; Shultz LD; Greiner D; N M; Shankar P
    J Virol; 2010 Mar; 84(5):2490-501. PubMed ID: 20015996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication.
    Suzuki Y; Chin WX; Han Q; Ichiyama K; Lee CH; Eyo ZW; Ebina H; Takahashi H; Takahashi C; Tan BH; Hishiki T; Ohba K; Matsuyama T; Koyanagi Y; Tan YJ; Sawasaki T; Chu JJ; Vasudevan SG; Sano K; Yamamoto N
    PLoS Pathog; 2016 Jan; 12(1):e1005357. PubMed ID: 26735137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate immune responses in human dendritic cells upon infection by chimeric yellow-fever dengue vaccine serotypes 1-4.
    Deauvieau F; Sanchez V; Balas C; Kennel A; DE Montfort A; Lang J; Guy B
    Am J Trop Med Hyg; 2007 Jan; 76(1):144-54. PubMed ID: 17255244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-α induces APOBEC3G, F, and A in immature dendritic cells and limits HIV-1 spread to CD4+ T cells.
    Mohanram V; Sköld AE; Bächle SM; Pathak SK; Spetz AL
    J Immunol; 2013 Apr; 190(7):3346-53. PubMed ID: 23427247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.
    Boonnak K; Slike BM; Burgess TH; Mason RM; Wu SJ; Sun P; Porter K; Rudiman IF; Yuwono D; Puthavathana P; Marovich MA
    J Virol; 2008 Apr; 82(8):3939-51. PubMed ID: 18272578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells.
    Limon-Flores AY; Perez-Tapia M; Estrada-Garcia I; Vaughan G; Escobar-Gutierrez A; Calderon-Amador J; Herrera-Rodriguez SE; Brizuela-Garcia A; Heras-Chavarria M; Flores-Langarica A; Cedillo-Barron L; Flores-Romo L
    Int J Exp Pathol; 2005 Oct; 86(5):323-34. PubMed ID: 16191104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro Cytokine Production by Dengue-Infected Human Monocyte-Derived Dendritic Cells.
    Cataneo AHD; Bordignon J; Wowk PF; Silveira GF
    Methods Mol Biol; 2022; 2409():223-234. PubMed ID: 34709645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus.
    Nightingale ZD; Patkar C; Rothman AL
    J Leukoc Biol; 2008 Oct; 84(4):1028-38. PubMed ID: 18653464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DEAD-box RNA helicase DDX3X inhibits DENV replication via regulating type one interferon pathway.
    Li G; Feng T; Pan W; Shi X; Dai J
    Biochem Biophys Res Commun; 2015 Jan; 456(1):327-32. PubMed ID: 25437271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crosstalk Between Dermal Fibroblasts and Dendritic Cells During Dengue Virus Infection.
    Montes-Gómez AE; García-Cordero J; Marcial-Juárez E; Shrivastava G; Visoso-Carvajal G; Juárez-Delgado FJ; Flores-Romo L; Sanchez-Torres MC; Santos-Argumedo L; Bustos-Arriaga J; Cedillo-Barrón L
    Front Immunol; 2020; 11():538240. PubMed ID: 33193307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of CD4+ T cell polarization by dengue virus-infected dendritic cells.
    Chase AJ; Medina FA; Muñoz-Jordán JL
    J Infect Dis; 2011 Jun; 203(12):1763-74. PubMed ID: 21606535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy.
    Huang X; Yue Y; Li D; Zhao Y; Qiu L; Chen J; Pan Y; Xi J; Wang X; Sun Q; Li Q
    Sci Rep; 2016 Feb; 6():22303. PubMed ID: 26923481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection.
    Boonnak K; Dambach KM; Donofrio GC; Tassaneetrithep B; Marovich MA
    J Virol; 2011 Feb; 85(4):1671-83. PubMed ID: 21123382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on dengue virus infection of human dendritic cells].
    Jiang ZY; Shi YJ; Sun HX
    Wei Sheng Wu Xue Bao; 2005 Aug; 45(4):598-600. PubMed ID: 16245879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA interference mediated silencing of Hsp60 gene in human monocytic myeloma cell line U937 revealed decreased dengue virus multiplication.
    Padwad YS; Mishra KP; Jain M; Chanda S; Karan D; Ganju L
    Immunobiology; 2009; 214(6):422-9. PubMed ID: 19261350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct expression of interferon-induced protein with tetratricopeptide repeats (IFIT) 1/2/3 and other antiviral genes between subsets of dendritic cells induced by dengue virus 2 infection.
    Zhang J; Sze DM; Yung BY; Tang P; Chen WJ; Chan KH; Leung PH
    Immunology; 2016 Aug; 148(4):363-76. PubMed ID: 27135915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of a monoclonal antibody against non-structural protein 3 of dengue-2 virus by intrasplenic injection.
    Chen Z; Tian Y; Liu L; An J
    Hybridoma (Larchmt); 2008 Dec; 27(6):467-71. PubMed ID: 19108619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production and characterization of a monoclonal antibody specific for NS3 protease and the ATPase region of Dengue-2 virus.
    García-Cordero J; Ramirez HR; Vazquez-Ochoa M; Gutierrez-Castañeda B; Santos-Argumedo L; Villegas-Sepúlveda N; Cedillo-Barrón L
    Hybridoma (Larchmt); 2005 Jun; 24(3):160-4. PubMed ID: 15943564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
    Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J
    Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.